Status:
COMPLETED
24-hour Oral Morphine Equivalent Based Opioid Prescribing After Surgery
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
The investigators will utilize the electronic health record to individualize pain therapy in surgical patients after hospital discharge using last 24-hour opioid intake as the decision variable for th...
Detailed Description
Prescription opioid overdose has emerged as a leading cause of death in the general population. Opioid-based therapy represents a corner-stone of post-operative pain management. With increasing emphas...
Eligibility Criteria
Inclusion
- Women ages at least 18 years of age having undergone Cesarean section surgery at the University of Colorado Hospital are eligible.
- Willingness to complete weekly surveys for 4 weeks after discharge.
- Anticipated to need half or less of the usually prescribed amount of opioids based on the amount of opioids taken in the last 24 hours prior to the opioid medication being written for discharge (only patients who took 22.5 MME or less opioids in the last 24 hours prior to the day of discharge will be eligible for this study).
Exclusion
- Patients under the age of 18 years.
- Patients returning to institutional settings (e.g. prison, jail, mental health facility).
- Pregnant women (patients will be approached after their C-section).
- Decisionally challenged patients.
- Blind or illiterate patients.
- Based on prior research factors such as emergency status, prior opioid use, repeat vs primary C-section, and associated procedures were not associated with post-discharge opioid use once the investigators adjusted for last-24 hour inpatient opioid use. Hence, these patients will not be excluded.
- Inclusion and exclusion criteria (including the amount of opioids taken in the last 24 hours prior to discharge) will be evaluated in the morning in patients scheduled to be discharged later that day.
Key Trial Info
Start Date :
October 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 13 2021
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04043143
Start Date
October 24 2019
End Date
January 13 2021
Last Update
October 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado
Aurora, Colorado, United States, 80045